Juvenile Myelomonocytic Leukemia - 20 Studies Found Recruiting : Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) : Juvenile Myelomonocytic Leukemia : 2005-09-09 : Biological: Stem Cell Transplant Active, not recruiting : Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia : Juvenile Myelomonocytic Leukemia : 2013-04-02 : Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Completed : Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia : Juvenile Myelomonocytic Leukemia : 2001-10-11 : Drug: tipifarnib Given orally Terminated : Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation : Leukemia : 2008-02-06 : Drug: cyclosporine Patients wi Terminated : Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia : Leukemia : 2007-07-27 : Drug: Etanercept 0.8 mg/kg Subcutaneously Once A Week for 90 Days Active, not recruiting : Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia : Acute Myelogenous Leukemia Myelodysplastic Syndrome : 2009-11-23 : Drug: Fludarabine Conditioning Terminated : Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML : Acute Myeloid Leukemia Juvenile Myelomonocytic Leukemia : 2008-04-29 : Drug: Gemtuzumab Ozogamicin Do Recruiting : Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) : Myelodysplastic Syndrome Leukemia, Myelomonocytic, Juvenile : 2015-04-14 : Drug: Azacitidine Other Name: Vidaza Recruiting : Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood : Myelodysplastic Syndromes Juvenile Myelomonocytic Leukemia : 2008-04-17 Recruiting : Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation : Acute Myelogenous Leukemia Acute Lymphoid Leukemia : 2015-01-05 : Drug: azacitidine 40mg/m2 IV/S Next >>>
